How can we unlock the full potential of human antibodies hidden in complex biological samples? Building on our previous articles about  Abvion's founding mission and the power of protein-level antibody discovery , I'm excited to share the technical backbone that makes it all possible. My name is Sem Tamara, and I'm Head of Discovery Technologies at Abvion. With a PhD from Prof Albert Heck's lab at Utrecht University, our company's birthplace, I've seen firsthand how mass spe

Abvion is pleased to announce that Health~Holland has awarded us funding through their prestigious SME Call to launch a collaborative project with Sanquin and Leiden University Medical Center.

Have you ever wondered why some antibody therapies work so well while others fall short? It often comes down to how we find and select them. In this article, we'll explain why protein-level discovery is a breakthrough for Abvion and the field of antibody therapeutics.

What if we could harness the human body’s own defenses to solve the toughest diseases? In this first article on the Abvion blog, we'll explore the scientific foundation of our biotech spin-off and its mission to realize a paradigm shift in human antibody discovery.